BrainStorm Cell Therapeutics, Inc. (BCLI) Stock Price Has Increased By 21%. Here’s what happened
BrainStorm Cell Therapeutics Inc. (BCLI) recently reported positive data, evaluating Cell therapy NurOwn or MSC-NTF cells as a treatment for progressive multiple sclerosis. The company stated that its phase two study observed improvements in secondary endpoints including diminishing inflammatory mechanisms, promoting repair and neurological functions. A total of 20 patients were enrolled, out of which […]